AMY BEYER: Open Payments
NPI 1679989784 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$746 in 29 payments from 10 companies in 2025. Trend: 2023 $4,921 · 2024 $544 · 2025 $746
Food & beverage: $746
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $316 |
| Dexcom, Inc. | 1 | $132 |
| PFIZER INC. | 4 | $83 |
| Lilly USA, LLC | 3 | $52 |
| Novo Nordisk Inc | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
| Lundbeck LLC | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: VRAYLAR, DEXCOM G7 GSS (161), NURTEC ODT, MOUNJARO, QULIPTA, Wegovy, REXULTI, UBRELVY.
Industry payments across VA — which companies pay providers there.
